Diagnostic delay in a French cohort of Crohn's disease patients

Journal of Crohn's and Colitis

Volumn 8, Issue 9, 2014, Pages 964-969

  Nahon, Stéphane ^a   Lahmek, Pierre ^b   Lesgourgues, Bruno ^a   Poupardin, Cécile ^a   Chaussade, Stanislas ^c   Peyrin Biroulet, Laurent ^d   Abitbol, Vered ^c  

^a Division of Gastroenterology and Hepatology GHI Le Raincy Montfermeil   (France)

^b Hôpitaux Universitaires Henri Mondor   (France)

^c université Paris Cité   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Crohn's disease; Diagnostic delay; Socioeconomic deprivation

Indexed keywords

ADULT; AGE; ARTICLE; COHORT ANALYSIS; CROHN DISEASE; DELAYED DIAGNOSIS; EDUCATIONAL STATUS; EPICES SCORE; FEMALE; FRANCE; GENDER; GEOGRAPHIC ORIGIN; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT REFERRAL; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SOCIAL STATUS; ADOLESCENT; DISEASE COURSE; FOLLOW UP; INCIDENCE; PROSPECTIVE STUDY; SOCIOECONOMICS; TIME; YOUNG ADULT; FRENCHMAN; MULTICENTER STUDY;

ADOLESCENT; ADULT; CROHN DISEASE; DELAYED DIAGNOSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84906791083     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.01.023     Document Type: Article

References (22)

1. Vavricka S.R., Spigaglia S.M., Rogler G., Pittet V., Michetti P., Felley C., et al. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis 2012, 18:496-505.
2. Marmot M., Allen J., Bell R., Bloomer E., Goldblatt P. WHO European review of social determinants of health and the health divide. Lancet 2012, 380:1011-1029.
3. Mackenbach J.P., Stirbu I., Roskam A.-J.R., Schaap M.M., Menvielle G., Leinsalu M., et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med 2008, 358:2468-2481.
4. Sewell J.L., Velayos F.S. Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness. Inflamm Bowel Dis 2013, 19:627-643.
5. Peyrin-Biroulet L., Cieza A., Sandborn W.J., Coenen M., Chowers Y., Hibi T., et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 2012, 61:241-247.
6. Peyrin-Biroulet L., Billioud V., D'Haens G., Panaccione R., Feagan B., Panés J., et al. Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process. Am J Gastroenterol 2012, 107:1770-1776.
7. Resman-Targoff B.H., Cicero M.P. Aggressive treatment of early rheumatoid arthritis: recognizing the window of opportunity and treating to target goals. Am J Manag Care 2010, 16:S249-S258. [Suppl.].
8. Colombel J.F., Sandborn W.J., Reinisch W., Mantzaris G.J., Kornbluth A., Rachmilewitz D., et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010, 362:1383-1395.
9. Nahon S., Lahmek P., Macaigne G., Faurel J.-P., Sass C., Howaizi M., et al. Socioeconomic deprivation does not influence the severity of Crohn's disease: results of a prospective multicenter study. Inflamm Bowel Dis 2009, 15:594-598.
10. Sass C., Guéguen R., Moulin J.J., Abric L., Dauphinot V., Dupré C., et al. Comparison of the individual deprivation index of the French Health Examination Centres and the administrative definition of deprivation. Sante Publique 2006, 18:513-522.
11. Beaugerie L., Seksik P., Nion-Larmurier I., Gendre J.-P., Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006, 130:650-656.
12. Schoepfer A.M., Dehlavi M.A., Fournier N., Safroneeva E., Straumann A., Pittet V., et al. Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol 2013, 108:1744-1753.
13. Peyrin-Biroulet L. Disease-Modifying Anti-Inflammatory Bowel Disease Drugs (DMAIDs): the missing term in the literature. Am J Gastroenterol 2013, 108:859-860.
14. Dignass A., Van Assche G., Lindsay J.O., Lémann M., Söderholm J., Colombel J.F., et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010, 4:28-62.
15. Burisch J., Pedersen N., Cukovic-Cavka S., Brinar M., Kaimakliotis I., Duricova D., et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2013, [Epub ahead of print, PubMed PMID: 23604131].
16. Chouraki V., Savoye G., Dauchet L., Vernier-Massouille G., Dupas J.-L., Merle V., et al. The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther 2011, 33:1133-1142.
17. Cosnes J., Cattan S., Blain A., Beaugerie L., Carbonnel F., Parc R., et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002, 8:244-250.
18. Thia K.T., Sandborn W.J., Harmsen W.S., Zinsmeister A.R., Loftus E.V. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 2010, 139:1147-1155.
19. Vavricka S.R., Brun L., Ballabeni P., Pittet V., Prinz Vavricka B.M., Zeitz J., et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011, 106:110-119.
20. Bihan H., Laurent S., Sass C., Nguyen G., Huot C., Moulin J.J., et al. Association among individual deprivation, glycemic control, and diabetes complications: the EPICES score. Diabetes Care 2005, 28:2680-2685.
21. Spivak W., Sockolow R., Rigas A. The relationship between insurance class and severity of presentation of inflammatory bowel disease in children. Am J Gastroenterol 1995, 90:982-987.
22. Nahon S., Lahmek P., Saas C., Durance C., Olympie A., Lesgourgues B., et al. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey. Inflamm Bowel Dis 2011, 17:1270-1276.